Pediatric thalassemic patients have higher incidence of asthma: A nationwide population-based retrospective cohort

Hsin-Yi Hsieh1, Lin-Chi Huang2, Hong-Ren Yu1

  • 1Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Plos One
|November 4, 2021
PubMed

Insights

Children with thalassemia have a significantly higher risk of developing asthma. Early diagnosis and prevention strategies are crucial for managing asthma in these children.

Area of Science:

  • Pediatric Hematology
  • Pulmonary Medicine
  • Epidemiology

Background:

  • Hemoglobinopathies are associated with increased pulmonary complications.
  • Limited research exists on the link between thalassemia and childhood asthma.

Purpose of the Study:

  • To investigate the association between thalassemia and the incidence of asthma in children.
  • To determine if children with thalassemia have a higher risk of developing asthma compared to controls.

Main Methods:

  • A retrospective cohort study using data from the National Health Insurance Research Database.
  • Matched 800 children with thalassemia to 3200 control children based on demographic and clinical factors.
  • Analyzed asthma incidence rates and adjusted hazard ratios.

Main Results:

  • Children with thalassemia showed a higher incidence of asthma (41.81 vs 25.70 per 1000 person-years).
  • Thalassemia was associated with an increased risk of asthma (adjusted hazard ratio = 1.37).
  • Boys with thalassemia had a higher risk of asthma, as did both atopic and nonatopic asthma.

Conclusions:

  • Children with thalassemia are more prone to developing asthma.
  • Increased vigilance for early asthma diagnosis and prevention of exacerbations is recommended for thalassemic children.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
826
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23